Literature DB >> 14639503

Nonsense-codon-mediated decay in human hereditary complement C3 deficiency.

Edimara S Reis1, Victor Nudelman, Lourdes Isaac.   

Abstract

C3 occupies a central position in the complement pathway, mediating such diverse functions as convertase activity, opsonization and anaphylotoxin production. The deficiency of this protein is a rare autosomal recessive inherited disease, characterized by severe recurrent infections and immune complex disorders. We looked for molecular alterations that could explain the C3 deficiency present in a Brazilian boy of consanguineous parents who suffered from recurrent bacterial infections. Using reverse-transcriptase polymerase chain reaction to amplify C3 mRNA from LPS-stimulated fibroblasts from the patient, we demonstrated that his C3 gene has no large structural aberrations. However, after sequencing the amplified and cloned products we found: (1). a L314P amino acid substitution; (2). silent mutations at codons P577, S798 and A1437; and finally, (3). an R848STer substitution that results in the production of a truncated protein. Densitometry studies revealed a lower C3 mRNA concentration in the patient's fibroblasts, suggesting an inherent instability of his C3 mRNA. Our results indicate the presence of a premature termination codon in the C3 gene that results in a lack of the protein in patient's serum, which correlates with the acceleration of C3 mRNA decay in the patient's fibroblasts. This mRNA instability is consistent with a nonsense-codon-mediated decay process that ensures the elimination of possible deleterious truncated proteins, which, in the case of constitutively expressed abundant proteins such as C3, may otherwise accumulate to significant levels, leading to toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639503     DOI: 10.1007/s00251-003-0624-3

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  38 in total

Review 1.  Systemic lupus erythematosus, complement deficiency, and apoptosis.

Authors:  M C Pickering; M Botto; P R Taylor; P J Lachmann; M J Walport
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  Genomic organization of human complement component C3.

Authors:  K Y Fong; M Botto; M J Walport; A K So
Journal:  Genomics       Date:  1990-08       Impact factor: 5.736

Review 3.  The multifunctional role of C3, the third component of complement.

Authors:  J D Lambris
Journal:  Immunol Today       Date:  1988-12

4.  Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

5.  Molecular basis of hereditary C3 deficiency.

Authors:  M Botto; K Y Fong; A K So; A Rudge; M J Walport
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Homozygous hereditary C3 deficiency due to a partial gene deletion.

Authors:  M Botto; K Y Fong; A K So; R Barlow; R Routier; B J Morley; M J Walport
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  Transcriptional and post-transcriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6.

Authors:  J O Minta; M Fung; B Paramaswara
Journal:  Biochim Biophys Acta       Date:  1998-11-08

8.  Human C'3: evidence for the liver as the primary site of synthesis.

Authors:  C A Alper; A M Johnson; A G Birtch; F D Moore
Journal:  Science       Date:  1969-01-17       Impact factor: 47.728

9.  A mechanism of action for anaphylatoxin C3a stimulation of mast cells.

Authors:  M Mousli; T E Hugli; Y Landry; C Bronner
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

10.  Antibody response to a T-dependent antigen requires B cell expression of complement receptors.

Authors:  D A Croix; J M Ahearn; A M Rosengard; S Han; G Kelsoe; M Ma; M C Carroll
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  2 in total

1.  Nonsense mutations in the rhodopsin gene that give rise to mild phenotypes trigger mRNA degradation in human cells by nonsense-mediated decay.

Authors:  Ramon Roman-Sanchez; Theodore G Wensel; John H Wilson
Journal:  Exp Eye Res       Date:  2015-09-26       Impact factor: 3.467

2.  Screening for C3 deficiency in newborns using microarrays.

Authors:  Magdalena Janzi; Ronald Sjöberg; Jinghong Wan; Björn Fischler; Ulrika von Döbeln; Lourdes Isaac; Peter Nilsson; Lennart Hammarström
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.